Immuno-oncology Assay Market Research Report By Product (Reagents & Kits, Instruments), By Assay Type (Immune Cell Profiling Assays, Cytokine Release Assays, Tumor Mutation Burden Assays, Co-Culture Assays, Cytotoxicity Assays, Others), By Technology (Enz
Description
The Immuno-oncology Assay Market will grow at a CAGR of 10.92%, reaching USD 12,406.18 Million by 2035. Demand for immuno-oncology assays is being driven by cancer-related factors such as increasing use of cancer drugs and reagents, instruments, and immune profiling, by which Asia-Pacific region comes out to be the rapid-growth market with increasing genomic biomarker testing adoption.
Key Drivers Behind the Growing Cancer Prevalence
The global cancer burden is increasing record rate by year, and this has been explained mainly by changes in people’s lives, environment, and demographics. The new cases for the period 2022–2025 are the highest in Asia (9.83M), and there are significant numbers in Europe (4.47M) and North America (2.85M) as well.
Segmentation and Sub-Segment Insights
By Product:
• Reagents & Kits: Essential assay preparation components.
• Instruments: Platforms enabling precise measurements.
By Assay Type:
• Immune Cell Profiling Assays: Characterize immune populations in detail.
• Cytokine Release Assays: Detects signaling molecules released.
• Tumor Mutation Burden Assays: Measures tumor genomic mutations.
• Co-Culture Assays: Analyze interactions between cell types.
• Cytotoxicity Assays: Evaluates immune-mediated cell death.
• Others: Additional assay types available.
By Technology:
• ELISA: Protein detection with specificity.
• Flow Cytometry: Fluorescent-based cell analysis.
• PCR-based Techniques: DNA/RNA amplification for detection.
• NGS: High-throughput sequencing technology.
• Mass Cytometry: Combines cytometry with mass spec.
• Others: Other novel assay methods.
By Application:
• Cancer Diagnosis: Detects tumors and biomarkers.
• Therapeutic Monitoring: Tracks treatment responses.
• Patient Stratification: Guides personalized therapy selection.
• Clinical Trials: Supports drug development studies.
By Indication:
• Lung Cancer: Diagnostics and monitoring focus.
• Colorectal Cancer: Biomarker-driven treatment support.
• Melanoma: Immune profiling for therapy planning.
• Ovarian Cancer: Tumor detection and analysis.
• Breast Cancer: Precision medicine support assays.
• Others: Other cancer indications considered.
By End User:
• Hospitals & Clinics: Routine clinical diagnostics.
• Pharma & Biotech Companies: Drug development research support.
• CROs: Outsourced clinical research services.
• Others: Academic and research institutions.
Regional Insights
North America and Europe are the major markets for immuno-oncology assays due to the high disease burden and robust precision-medicine initiatives. The Asia-Pacific region is speeding up the process by increasing cancer incidences and investment in sophisticated diagnostics, while MEA is slowly extending as an increase in immunotherapy adoption is being witnessed.
Immunotherapy Momentum Strengthens Market Potential
The ongoing dramatic increase in global immunotherapy approvals over 150 since 2011 and still rapidly increasing continues to be a major driver for strong demand for biomarker testing and immune profiling. In the situation where aging populations are one of the reasons for the cancer incidence rise, very high-precision assays are still necessary to guide future treatments.
Key Report Attributes
• Market Size 2024: USD 3,954.87 Million
• Market Size 2035: USD 12,406.18 Million
• CAGR (2025-2035): 10.92%
• Base Year: 2025
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Product: Reagents & Kits - 10.36%, Instruments - 12.07%.
• By Assay Type: Immune Cell Profiling Assays - 11.95%, Cytokine Release Assays - 9.54%.
• By Technology: Enzyme-Linked Immunosorbent Assay - 8.64%, Flow Cytometry - 10.90%.
• By Application: Cancer Diagnosis - 10.60%, Therapeutic Monitoring - 9.42%.
• By Indication: Lung Cancer - 12.03%, Colorectal Cancer - 7.18%.
• By End User: Hospitals & Clinics -10.93%, Pharmaceutical & Biotechnology Companies - 10.17%.
Key Drivers Behind the Growing Cancer Prevalence
The global cancer burden is increasing record rate by year, and this has been explained mainly by changes in people’s lives, environment, and demographics. The new cases for the period 2022–2025 are the highest in Asia (9.83M), and there are significant numbers in Europe (4.47M) and North America (2.85M) as well.
Segmentation and Sub-Segment Insights
By Product:
• Reagents & Kits: Essential assay preparation components.
• Instruments: Platforms enabling precise measurements.
By Assay Type:
• Immune Cell Profiling Assays: Characterize immune populations in detail.
• Cytokine Release Assays: Detects signaling molecules released.
• Tumor Mutation Burden Assays: Measures tumor genomic mutations.
• Co-Culture Assays: Analyze interactions between cell types.
• Cytotoxicity Assays: Evaluates immune-mediated cell death.
• Others: Additional assay types available.
By Technology:
• ELISA: Protein detection with specificity.
• Flow Cytometry: Fluorescent-based cell analysis.
• PCR-based Techniques: DNA/RNA amplification for detection.
• NGS: High-throughput sequencing technology.
• Mass Cytometry: Combines cytometry with mass spec.
• Others: Other novel assay methods.
By Application:
• Cancer Diagnosis: Detects tumors and biomarkers.
• Therapeutic Monitoring: Tracks treatment responses.
• Patient Stratification: Guides personalized therapy selection.
• Clinical Trials: Supports drug development studies.
By Indication:
• Lung Cancer: Diagnostics and monitoring focus.
• Colorectal Cancer: Biomarker-driven treatment support.
• Melanoma: Immune profiling for therapy planning.
• Ovarian Cancer: Tumor detection and analysis.
• Breast Cancer: Precision medicine support assays.
• Others: Other cancer indications considered.
By End User:
• Hospitals & Clinics: Routine clinical diagnostics.
• Pharma & Biotech Companies: Drug development research support.
• CROs: Outsourced clinical research services.
• Others: Academic and research institutions.
Regional Insights
North America and Europe are the major markets for immuno-oncology assays due to the high disease burden and robust precision-medicine initiatives. The Asia-Pacific region is speeding up the process by increasing cancer incidences and investment in sophisticated diagnostics, while MEA is slowly extending as an increase in immunotherapy adoption is being witnessed.
Immunotherapy Momentum Strengthens Market Potential
The ongoing dramatic increase in global immunotherapy approvals over 150 since 2011 and still rapidly increasing continues to be a major driver for strong demand for biomarker testing and immune profiling. In the situation where aging populations are one of the reasons for the cancer incidence rise, very high-precision assays are still necessary to guide future treatments.
Key Report Attributes
• Market Size 2024: USD 3,954.87 Million
• Market Size 2035: USD 12,406.18 Million
• CAGR (2025-2035): 10.92%
• Base Year: 2025
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Product: Reagents & Kits - 10.36%, Instruments - 12.07%.
• By Assay Type: Immune Cell Profiling Assays - 11.95%, Cytokine Release Assays - 9.54%.
• By Technology: Enzyme-Linked Immunosorbent Assay - 8.64%, Flow Cytometry - 10.90%.
• By Application: Cancer Diagnosis - 10.60%, Therapeutic Monitoring - 9.42%.
• By Indication: Lung Cancer - 12.03%, Colorectal Cancer - 7.18%.
• By End User: Hospitals & Clinics -10.93%, Pharmaceutical & Biotechnology Companies - 10.17%.
Table of Contents
231 Pages
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.5.3 Primary Research: Regional Coverage
- 3.6 Approaches For Market Size Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.7 Data Forecasting
- 3.7.1 Data Forecasting Type
- 3.8 Data Modeling
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modeling:
- 3.9 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Rising Incidence Of Cancer
- 4.2.2 Government And Private Funding For Cancer Research
- 4.3 Restraints
- 4.3.1 High Cost Of Immuno-oncology Assays
- 4.3.2 Lack Of Skilled Workforce
- 4.4 Opportunity
- 4.4.1 Growing Geriatric Population
- 4.4.2 Technological Advancements
- 5 Market Factor Analysis
- 5.1 Porter's Five Forces Model
- 5.1.1 Threat Of New Entrants
- 5.1.2 Bargaining Power Of Suppliers
- 5.1.3 Threat Of Substitutes
- 5.1.4 Bargaining Power Of Buyers
- 5.1.5 Intensity Of Rivalry
- 5.2 Impact Of Covid-19 On The Global Immuno-oncology Assay Market
- 6 Global Immuno-oncology Assay Market, By Product
- 6.1 Overview
- 6.2 Reagents & Kits
- 6.3 Instruments
- 7 Global Immuno-oncology Assay Market, By Assay Type
- 7.1 Overview
- 7.2 Immune Cell Profiling Assays
- 7.3 Cytokine Release Assays
- 7.4 Tumor Mutation Burden Assays
- 7.5 Co-culture Assays
- 7.6 Cytotoxicity Assays
- 7.7 Others
- 8 Global Immuno-oncology Assay Market, By Technology
- 8.1 Overview
- 8.2 Enzyme-linked Immunosorbent Assay
- 8.3 Flow Cytometry
- 8.4 Pcr-based Techniques
- 8.5 Next-generation Sequencing (Ngs)
- 8.6 Mass Cytometry
- 8.7 Others
- 9 Global Immuno-oncology Assay Market, By Application
- 9.1 Overview
- 9.2 Cancer Diagnosis
- 9.3 Therapeutic Monitoring
- 9.4 Patient Stratification
- 9.5 Clinical Trials
- 10 Global Immuno-oncology Assay Market, By Indication
- 10.1 Overview
- 10.2 Lung Cancer
- 10.3 Colorectal Cancer
- 10.4 Melanoma
- 10.5 Ovarian Cancer
- 10.6 Breast Cancer
- 10.7 Others
- 11 Global Immuno-oncology Assay Market, By End User
- 11.1 Overview
- 11.2 Hospitals & Clinics
- 11.3 Pharmaceutical & Biotechnology Companies
- 11.4 Contract Research Organizations (Cros)
- 11.5 Others
- 12 Global Immuno-oncology Assay Market, By Region
- 12.1 Overview
- 12.2 North America
- 12.2.1 Us
- 12.2.2 Canada
- 12.3 Europe
- 12.3.1 Germany
- 12.3.2 France
- 12.3.3 Uk
- 12.3.4 Italy
- 12.3.5 Spain
- 12.3.6 Russia
- 12.3.7 Rest Of Europe
- 12.4 Asia-pacific
- 12.4.1 China
- 12.4.2 India
- 12.4.3 Japan
- 12.4.4 South Korea
- 12.4.5 Malaysia
- 12.4.6 Thailand
- 12.4.7 Indonesia
- 12.4.8 Rest Of Asia-pacific
- 12.5 South America
- 12.5.1 Brazil
- 12.5.2 Mexico
- 12.5.3 Argentina
- 12.5.4 Rest Of South America
- 12.6 Middle East And Africa
- 12.6.1 Gcc Countries
- 12.6.2 South Africa
- 12.6.3 Rest Of Middle East And Africa
- 13 Competitive Landscape
- 13.1 Introduction
- 13.2 Market Share Analysis, 2024
- 13.3 Competitor Dashboard
- 13.4 Public Players Stock Summary
- 13.5 Comparative Analysis: Key Players Financial
- 13.6 Key Developments & Growth Strategies
- 13.6.1 Product Launch
- 13.6.2 Partnership
- 13.6.3 Recognition
- 13.6.4 Acquisition
- 13.6.5 Integration
- 13.6.6 Strategic Innovation
- 14 Company Profiles
- 14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Company Overview
- 14.1.2 Financial Overview
- 14.1.3 Products Offered
- 14.1.4 Key Developments
- 14.1.5 Swot Analysis
- 14.1.6 Key Strategies
- 14.2 Qiagen
- 14.2.1 Company Overview
- 14.2.2 Financial Overview
- 14.2.3 Products Offered
- 14.2.4 Key Developments
- 14.2.5 Swot Analysis
- 14.2.6 Key Strategies
- 14.3 Merck Kgaa
- 14.3.1 Company Overview
- 14.3.2 Financial Overview
- 14.3.3 Products Offered
- 14.3.4 Key Developments
- 14.3.5 Swot Analysis
- 14.3.6 Key Strategies
- 14.4 Sartorius Ag
- 14.4.1 Company Overview
- 14.4.2 Financial Overview
- 14.4.3 Products Offered
- 14.4.4 Key Developments
- 14.4.5 Key Strategies
- 14.7 F. Hoffmann-la Roche Ltd.
- 14.7.1 Company Overview
- 14.7.2 Financial Overview
- 14.7.3 Products Offered
- 14.7.4 Key Developments
- 14.7.5 Swot Analysis
- 14.7.6 Key Strategies
- 14.8 Agilent Technologies Inc.
- 14.8.1 Company Overview
- 14.8.2 Financial Overview
- 14.8.3 Products Offered
- 14.8.4 Key Developments
- 14.8.5 Swot Analysis
- 14.8.6 Key Strategies
- 14.9 Illumina, Inc.
- 14.9.1 Company Overview
- 14.9.2 Financial Overview
- 14.9.3 Products Offered
- 14.9.4 Key Developments
- 14.9.5 Key Strategies
- 14.10 Axion Biosystems, Inc
- 14.10.1 Company Overview
- 14.10.2 Financial Overview
- 14.10.3 Products Offered
- 14.10.4 Key Developments
- 14.10.5 Key Strategies
- 15 Data Citations
- List Of Tables
- Table 1 Qfd Modeling For Market Share Assessment
- Table 2 Global Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 3 Global Immuno-oncology Assay Market, For Reagents & Kits, By Region, 2019–2035 (Usd Million)
- Table 4 Global Immuno-oncology Assay Market, For Instruments, By Region, 2019–2035 (Usd Million)
- Table 5 Global Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 6 Global Immuno-oncology Assay Market, For Immune Cell Profiling Assays, By Region, 2019–2035 (Usd Million)
- Table 7 Global Immuno-oncology Assay Market, For Cytokine Release Assays, By Region, 2019–2035 (Usd Million)
- Table 8 Global Immuno-oncology Assay Market, For Tumor Mutation Burden Assays, By Region, 2019–2035 (Usd Million)
- Table 9 Global Immuno-oncology Assay Market, For Co-culture Assays, By Region, 2019–2035 (Usd Million)
- Table 10 Global Immuno-oncology Assay Market, For Cytotoxicity Assays, By Region, 2019–2035 (Usd Million)
- Table 11 Global Immuno-oncology Assay Market, For Others, By Region, 2019–2035 (Usd Million)
- Table 12 Global Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 13 Global Immuno-oncology Assay Market, For Enzyme-linked Immunosorbent Assay, By Region, 2019–2035 (Usd
- Million)
- Table 14 Global Immuno-oncology Assay Market, For Flow Cytometry, By Region, 2019–2035 (Usd Million)
- Table 15 Global Immuno-oncology Assay Market, For Pcr-based Techniques, By Region, 2019–2035 (Usd Million)
- Table 16 Global Immuno-oncology Assay Market, For Next-generation Sequencing (Ngs), By Region, 2019–2035 (Usd Million)
- Table 17 Global Immuno-oncology Assay Market, For Mass Cytometry, By Region, 2019–2035 (Usd Million)
- Table 18 Global Immuno-oncology Assay Market, For Others, By Region, 2019–2035 (Usd Million)
- Table 19 Global Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 20 Global Immuno-oncology Assay Market, For Cancer Diagnosis, By Region, 2019–2035 (Usd Million)
- Table 21 Global Immuno-oncology Assay Market, For Therapeutic Monitoring, By Region, 2019–2035 (Usd Million)
- Table 22 Global Immuno-oncology Assay Market, For Patient Stratification, By Region, 2019–2035 (Usd Million)
- Table 23 Global Immuno-oncology Assay Market, For Clinical Trials, By Region, 2019–2035 (Usd Million)
- Table 24 Global Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 25 Global Immuno-oncology Assay Market, For Lung Cancer, By Region, 2019–2035 (Usd Million)
- Table 26 Global Immuno-oncology Assay Market, For Colorectal Cancer, By Region, 2019–2035 (Usd Million)
- Table 27 Global Immuno-oncology Assay Market, For Melanoma, By Region, 2019–2035 (Usd Million)
- Table 28 Global Immuno-oncology Assay Market, For Ovarian Cancer, By Region, 2019–2035 (Usd Million)
- Table 29 Global Immuno-oncology Assay Market, For Breast Cancer, By Region, 2019–2035 (Usd Million)
- Table 30 Global Immuno-oncology Assay Market, For Others, By Region, 2019–2035 (Usd Million)
- Table 31 Global Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 32 Global Immuno-oncology Assay Market, For Hospitals & Clinics, By Region, 2019–2035 (Usd Million)
- Table 33 Global Immuno-oncology Assay Market, For Pharmaceutical & Biotechnology Companies, By Region, 2019–2035
- (Usd Million)
- Table 34 Global Immuno-oncology Assay Market, For Contract Research Organizations (Cros), By Region, 2019–2035 (Usd
- Million)
- Table 35 Global Immuno-oncology Assay Market, For Others, By Region, 2019–2035 (Usd Million)
- Table 36 Global Immuno-oncology Assay Market, By Region, 2019-2035 (Usd Million)
- Table 37 North America Immuno-oncology Assay Market, By Country, 2019-2035 (Usd Million)
- Table 38 North America: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 39 North America: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 40 North America: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 41 North America: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 42 North America: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 43 North America: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 44 Us: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 45 Us: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 46 Us: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 47 Us: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 48 Us: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 49 Us: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 50 Canada: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 51 Canada: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 52 Canada: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 53 Canada: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 54 Canada: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 55 Canada: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 56 Europe Immuno-oncology Assay Market, By Country, 2019-2035 (Usd Million)
- Table 57 Europe: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 58 Europe: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 59 Europe: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 60 Europe: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 61 Europe: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 62 Europe: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 63 Germany: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 64 Germany: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 65 Germany: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 66 Germany: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 67 Germany: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 68 Germany: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 69 France: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 70 France: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 71 France: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 72 France: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 73 France: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 74 France: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 75 Uk: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 76 Uk: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 77 Uk: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 78 Uk: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 79 Uk: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 80 Uk: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 81 Italy: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 82 Italy: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 83 Italy: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 84 Italy: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 85 Italy: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 86 Italy: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 87 Spain: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 88 Spain: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 89 Spain: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 90 Spain: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 91 Spain: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 92 Spain: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 93 Russia: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 94 Russia: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 95 Russia: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 96 Russia: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 97 Russia: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 98 Russia: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 99 Rest Of Europe: Immuno-oncology Assay Market, By Product, 2019-2035 (Usd Million)
- Table 100 Rest Of Europe: Immuno-oncology Assay Market, By Assay Type, 2019-2035 (Usd Million)
- Table 101 Rest Of Europe: Immuno-oncology Assay Market, By Technology, 2019-2035 (Usd Million)
- Table 102 Rest Of Europe: Immuno-oncology Assay Market, By Application, 2019-2035 (Usd Million)
- Table 103 Rest Of Europe: Immuno-oncology Assay Market, By Indication, 2019-2035 (Usd Million)
- Table 104 Rest Of Europe: Immuno-oncology Assay Market, By End User, 2019-2035 (Usd Million)
- Table 105 Asia-pacific: Immuno-oncology Assay Market, By Country, 2019–2035 (Usd Million)
- Table 106 Asia-pacific: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 107 Asia-pacific: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 108 Asia-pacific: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 109 Asia-pacific: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 110 Asia-pacific: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 111 Asia-pacific: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 112 China: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 113 China: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 114 China: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 115 China: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 116 China: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 117 China: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 118 India: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 119 India: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 120 India: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 121 India: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 122 India: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 123 India: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 124 Japan: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 125 Japan: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 126 Japan: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 127 Japan: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 128 Japan: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 129 Japan: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 130 South Korea: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 131 South Korea: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 132 South Korea: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 133 South Korea: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 134 South Korea: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 135 South Korea: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 136 Malaysia: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 137 Malaysia: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 138 Malaysia: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 139 Malaysia: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 140 Malaysia: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 141 Malaysia: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 142 Thailand: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 143 Thailand: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 144 Thailand: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 145 Thailand: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 146 Thailand: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 147 Thailand: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 148 Indonesia: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 149 Indonesia: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 150 Indonesia: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 151 Indonesia: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 152 Indonesia: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 153 Indonesia: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 154 Rest Of Asia-pacific: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 155 Rest Of Asia-pacific: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 156 Rest Of Asia-pacific: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 157 Rest Of Asia-pacific: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 158 Rest Of Asia-pacific: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 159 Rest Of Asia-pacific: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 160 South America: Immuno-oncology Assay Market, By Country, 2019–2035 (Usd Million)
- Table 161 South America: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 162 South America: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 163 South America: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 164 South America: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 165 South America: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 166 South America: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 167 Brazil: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 168 Brazil: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 169 Brazil: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 170 Brazil: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 171 Brazil: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 172 Brazil: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 173 Mexico: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 174 Mexico: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 175 Mexico: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 176 Mexico: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 177 Mexico: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 178 Mexico: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 179 Argentina: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 180 Argentina: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 181 Argentina: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 182 Argentina: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 183 Argentina: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 184 Argentina: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 185 Rest Of South America: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 186 Rest Of South America: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 187 Rest Of South America: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 188 Rest Of South America: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 189 Rest Of South America: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 190 Rest Of South America: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 191 Middle East And Africa: Immuno-oncology Assay Market, By Country, 2019–2035 (Usd Million)
- Table 192 Middle East And Africa: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 193 Middle East And Africa: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 194 Middle East And Africa: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 195 Middle East And Africa: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 196 Middle East And Africa: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 197 Middle East And Africa: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 198 Gcc Countries: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 199 Gcc Countries: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 200 Gcc Countries: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 201 Gcc Countries: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 202 Gcc Countries: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 203 Gcc Countries: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 204 South Africa: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 205 South Africa: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 206 South Africa: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 207 South Africa: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 208 South Africa: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 209 South Africa: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 210 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By Product, 2019–2035 (Usd Million)
- Table 211 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By Assay Type, 2019–2035 (Usd Million)
- Table 212 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By Technology, 2019–2035 (Usd Million)
- Table 213 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By Application, 2019–2035 (Usd Million)
- Table 214 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By Indication, 2019–2035 (Usd Million)
- Table 215 Rest Of Middle East And Africa: Immuno-oncology Assay Market, By End User, 2019–2035 (Usd Million)
- Table 216 Product Launch
- Table 217 Partnership/Collaboration
- Table 218 Agreement
- Table 219 Acquisition/Expansion
- Table 220 Integration
- Table 221 Strategic Innovation
- Table 222 Thermo Fisher Scientific Inc.: Products Offered
- Table 223 Qiagen: Products Offered
- Table 224 Qiagen: Key Developments
- Table 225 Merck Kgaa: Products Offered
- Table 226 Sartorius Ag: Products Offered
- Table 227 Sartorius Ag: Key Developments
- Table 229 Bio-techne: Products Offered
- Table 230 F. Hoffmann-la Roche Ltd.: Products Offered
- Table 231 F. Hoffmann-la Roche Ltd.: Products Offered
- Table 232 Agilent Technologies Inc.: Products Offered
- Table 233 Agilent Technologies Inc.: Products Offered
- Table 234 Illumina, Inc.: Products Offered
- Table 235 Illumina, Inc.: Products Offered
- Table 236 Axion biosystems, Inc.: Products Offered
- Table 237 Axion biosystems, Inc.: Key Developments
- List Of Figures
- Figure 1 Global Immuno-oncology Assay Market: Structure
- Figure 2 Global Immuno-oncology Assay Market: Market Growth Factor Analysis (2019-2035)
- Figure 3 Driver Impact Analysis (2024-2035)
- Figure 4 Restraint Impact Analysis (2024-2035)
- Figure 5 Porter's Five Forces Analysis: Global Immuno-oncology Assay Market
- Figure 6 Global Immuno-oncology Assay Market, By Product, 2024 & 2035 (Usd Million)
- Figure 7 Global Immuno-oncology Assay Market Share (%), By Product, 2024
- Figure 8 Global Immuno-oncology Assay Market, By Assay Type, 2024 & 2035 (Usd Million)
- Figure 9 Global Immuno-oncology Assay Market Share (%), By Assay Type, 2024
- Figure 10 Global Immuno-oncology Assay Market, By Technology, 2024 & 2035 (Usd Million)
- Figure 11 Global Immuno-oncology Assay Market Share (%), By Technology, 2024
- Figure 12 Global Immuno-oncology Assay Market, By Application, 2024 & 2035 (Usd Million)
- Figure 13 Global Immuno-oncology Assay Market Share (%), By Application, 2024
- Figure 14 Global Immuno-oncology Assay Market, By Indication, 2024 & 2035 (Usd Million)
- Figure 15 Global Immuno-oncology Assay Market Share (%), By Indication, 2024
- Figure 16 Global Immuno-oncology Assay Market, By End User, 2024 & 2035 (Usd Million)
- Figure 17 Global Immuno-oncology Assay Market Share (%), By End User, 2024
- Figure 18 Global Immuno-oncology Assay Market, By Region, 2024 & 2035 (Usd Million)
- Figure 19 Global Immuno-oncology Assay Market Share (%), By Region, 2024
- Figure 20 North America Market Analysis: Immuno-oncology Assay Market, 2019-2035 (Usd Million)
- Figure 21 North America Immuno-oncology Assay Market, By Region, 2024 & 2035 (Usd Million)
- Figure 22 North America Immuno-oncology Assay Market Share (%), By Country, 2024
- Figure 23 Europe Market Analysis: Immuno-oncology Assay Market, 2019-2035 (Usd Million)
- Figure 24 Europe Immuno-oncology Assay Market, By Region, 2024 & 2035 (Usd Million)
- Figure 25 Europe Immuno-oncology Assay Market Share (%), By Country, 2024
- Figure 26 Asia-pacific Market Analysis: Immuno-oncology Assay Market, 2019-2035 (Usd Million)
- Figure 27 Asia-pacific: Immuno-oncology Assay Market Share, By Country, 2024 & 2035 (Usd Million)
- Figure 28 Asia-pacific: Immuno-oncology Assay Market Share, By Country, 2024 (%)
- Figure 29 South America Market Analysis: Immuno-oncology Assay Market, 2019-2035 (Usd Million)
- Figure 30 South America: Immuno-oncology Assay Market Share, By Country, 2024 & 2035 (Usd Million)
- Figure 31 South America: Immuno-oncology Assay Market Share, By Country, 2024 (%)
- Figure 32 Middle East And Africa Market Analysis: Immuno-oncology Assay Market, 2019-2035 (Usd Million)
- Figure 33 Middle East And Africa: Immuno-oncology Assay Market Share, By Country, 2024 & 2035 (Usd Million)
- Figure 34 Middle East And Africa: Immuno-oncology Assay Market Share, By Country, 2024 (%)
- Figure 35 Global Immuno-oncology Assay Market Players: Competitive Analysis, 2024
- Figure 36 Competitor Dashboard: Global Immuno-oncology Assay Market
- Figure 37 Thermo Fisher Scientific Inc.: Financial Overview Snapshot
- Figure 38 Thermo Fisher Scientific Inc.: Swot Analysis
- Figure 39 Qiagen: Financial Overview Snapshot
- Figure 40 Qiagen: Swot Analysis
- Figure 41 Merck Kgaa: Financial Overview Snapshot
- Figure 42 Merck Kgaa: Swot Analysis
- Figure 43 Sartorius Ag: Financial Overview Snapshot
- Figure 45 Bio-techne: Financial Overview Snapshot
- Figure 46 F. Hoffmann-la Roche Ltd.: Financial Overview Snapshot
- Figure 47 F. Hoffmann-la Roche Ltd.: Swot Analysis
- Figure 48 Agilent Technologies Inc.: Financial Overview Snapshot
- Figure 49 Agilent Technologies Inc.: Swot Analysis
- Figure 50 Illumina, Inc.: Financial Overview Snapshot
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
